TickerFacts.

UL Solutions Inc. (ULS): Operating Income

Annual figures by period end, from SEC filings.

$522.00M
Year ended 2025-12-31
$562.00M
Trailing 12 months to 2026-06-30
+8.2%
3-year compound annual growth
2022-12-31: $412.00M2023-12-31: $368.00M2024-12-31: $462.00M2025-12-31: $522.00M$522.00M
2022-12-31 Operating Income (USD) 2025-12-31
Period endedOperating IncomeChange YoYSource filing
2025-12-31$522.00M+13.0%2026-02-19, From 2025-01-01
2024-12-31$462.00M+25.5%2026-02-19, From 2024-01-01
2023-12-31$368.00M-10.7%2026-02-19, From 2023-01-01
2022-12-31$412.00Mn/a2025-02-20, From 2022-01-01

Operating Income at similar companies

Companies with the same SEC industry code (Services-Testing Laboratories), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedOperating IncomeChange YoY
UL Solutions Inc. (ULS)2025-12-31$522.00M+13.0%
NeoGenomics Inc (NEO)2025-12-31-$115.88Mn/m
20/20 Biolabs, Inc. (AIDX)2025-12-31-$3.33Mn/m
Hypha Labs, Inc. (FUNI)2025-09-30-$3.00Mn/m

Compare ULS, NEO, AIDX, FUNI side by side · Screen every company in Services-Testing Laboratories ↗